Dr. Mohamad Al-Jarrah, MD

Dr. Al-Jarrah practices at Corewell Health Beaumont Troy Hospital in Troy, Michigan, part of Corewell Health.

Dr. Al-Jarrah's NPI, 1154382919, was assigned on March 31, 2006. Dr. Al-Jarrah holds Michigan license MA057471.

Dr. Al-Jarrah's primary practice is Corewell Health Beaumont Troy Hospital, at 44201 Dequindre Road, Troy, MI 48085 in Oakland County. The practice phone is (248) 964-8800.

Dr. Al-Jarrah's primary practice is Corewell Health Beaumont Troy Hospital in Troy, Michigan, part of Corewell Health. Dr. Al-Jarrah is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Associated Physicians Dearborn. Dmand AI also links Dr. Al-Jarrah to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Jarrah practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Al-Jarrah's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Al-Jarrah is board certified in internal medicine by the American Board of Internal Medicine. Dr. Al-Jarrah is licensed in Michigan.

CMS data shows 1,085 Medicare services from Dr. Al-Jarrah across 16 procedure codes in 2024, for 301 Medicare patients. Medicare paid $43,246 for them. Every service was in an office.

CMS counts 301 Medicare patients who saw Dr. Al-Jarrah in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Al-Jarrah's median patient age at 37, with 58% women.

In 2024, Dr. Al-Jarrah wrote 1,394 Medicare Part D claims for 363 patients. 79% of them were for generic drugs. CMS names the drug for 1,089 of them, across 40 drugs with 11 or more claims each, at $104,561 in total drug cost. In 2023, CMS named 653 claims across 25 drugs.

Dr. Al-Jarrah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 23 general payments to Dr. Al-Jarrah from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Medtronic Vascular, Inc. paid the most, $120.